CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Enzon Pharmaceuticals, Inc. Company Snapshot
Enzon Pharmaceuticals, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzon Pharmaceuticals with three other companies in this sector in the United States: Curis, Inc. (2016 sales of $7.53 million of which 100% was Therapeutic Drug Dev), Protalix Biotherapeutics Inc ($9.20 million of which 100% was Biotherapeutic Products), and Aviragen Therapeutics Inc ($9.30 million of which 100% was Antibody Products).

Sales Analysis. During the year ended December of 2016, sales at Enzon Pharmaceuticals were $8.38 million. This is a sharp decrease of 52.0% versus 2015, when the company's sales were $17.46 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Enzon Pharmaceuticals, Inc.
  Stock Performance Chart for Enzon Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): .24
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks -37.5%  
4 Weeks -33.4%   52 Weeks -32.0%  
 
Enzon Pharmaceuticals, Inc. Key Data:
  Ticker: ENZN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 8,377,000
(Year Ending Jan 2017).
Employees: 1
  Currency: U.S. Dollars Market Cap: 10,523,076
  Fiscal Yr Ends: December Shares Outstanding: 44,214,603
  Share Type: Common Closely Held Shares: 2,507,391
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.